Thioctic Acid Amide

Thioctic Acid Amide

SCHEMBL50599

NC(=O)CCCCC1CCSS1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 1.00
TARDBP Q13148 2/20 1.00
HSD17B10 Q99714 2/20 0.74
CYP2C9 P11712 1/20 0.74
MEN1 O00255 1/20 0.74
NR1I2 O75469 1/20 0.74
ALDH1A1 P00352 1/20 0.74
LMNA P02545 1/20 0.74
POLB P06746 1/20 0.74
THRB P10828 1/20 0.74
TSHR P16473 1/20 0.74
ACHE P22303 1/20 0.74
APEX1 P27695 1/20 0.74
RECQL P46063 1/20 0.74
BLM P54132 1/20 0.74
PMP22 Q01453 1/20 0.74
TDP1 Q9NUW8 1/20 0.74
SAE1 Q9UBE0 1/20 0.74
UBA2 Q9UBT2 1/20 0.74
L3MBTL1 Q9Y468 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thioctic Acid Amide SCHEMBL4380181 1.00 KMT2A (1.00) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid Amide SCHEMBL13093778 1.00 KMT2A (1.00) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid Amide SCHEMBL41833 1.00 KMT2A (1.00) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL27494633 0.98 KMT2A (0.96) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid Amide SCHEMBL28076123 0.98 KMT2A (0.96) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid Amide SCHEMBL16653981 0.98 KMT2A (0.96) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL29249630 0.98 KMT2A (0.96) KMT2ATARDBPHSD17B10CYP2C9MEN1
SCHEMBL7841850 0.94 KMT2A (0.89) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid Amide SCHEMBL3400641 0.93 KMT2A (0.87) KMT2ATARDBPHSD17B10CYP2C9MEN1
Thioctic Acid Amide SCHEMBL1895286 0.93 HSD17B10 (0.87) KMT2ATARDBPHSD17B10CYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3965 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
US-20260034043-A1 NAIL COMPOSITIONS INCLUDING SULFUR-CONTAINING AGENTS AND USES THEREOF LIQWD INC (US) 2026-02-05 US claimed
EP-4679087-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 EP claimed
US-12453495-B2 Hormone electrochemical biosensor TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-28 US claimed
WO-2025129192-A1 POLYMER BRUSH COMPOSITIONS INCLUDING CHAIN-END-IMMOBILIZED COFACTORS AND METHODS FOR THE PRODUCTION THEREOF CASCADE BIOCATALYSTS, INC (US) 2025-06-19 WO claimed
WO-2025121943-A1 CANCER CELL-TARGETING DRUG DELIVERY CARRIER COMPRISING CAMPTOTHECIN-IRGD CONJUGATE, AND MANUFACTURING METHOD THEREFOR 순천향대학교 산학협력단 2025-06-12 WO claimed
CN-119823707-A Hot-melt injectable adhesive, and preparation method and application thereof 四川大学 2025-04-15 CN claimed
EP-4531929-A1 MULTIFUNCTIONAL HYBRID CELLULOSE NANOCRYSTALS-GOLD NANOPLATFORM AND USE THEREOF IN MEDICINE Universita' Degli Studi di Firenze (IT) 2025-04-09 EP claimed
US-20250084433-A1 Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use Thereof CELLTRION INC. (KR) 2025-03-13 US claimed
WO-2025019764-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS MATTERWORKS INC (US) 2025-01-23 WO claimed
WO-1995031194-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO HOWARD K (US) 1995-11-23 WO claimed
US-5463093-A Palladium complexes and methods for using same in the treatment of tumors or Psoriasis GARNETT MCKEEN LABORATORY, INC. 1995-10-31 US claimed
WO-1995014466-A1 NOVEL PALLADIUM COMPLEXES AND METHODS FOR USING SAME IN THE TREATMENT OF TUMORS AND PSORIASIS GARNETT MERRILL (US) 1995-06-01 WO claimed
WO-1995001096-A1 PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR TREATMENT OF NEUROLOGICAL DISEASES AND ETIOLOGICALLY RELATED SYMPTOMOLOGY SHAPIRO HOWARD K (US) 1995-01-12 WO claimed
EP-0568647-A1 PRODUCTION OF ENZYMATICALLY ACTIVE GLUCOCEREBROSIDASE FROM RECOMBINANT CELLS. GENZYME CORP (US) 1993-11-10 EP claimed
WO-1992013067-A1 PRODUCTION OF ENZYMATICALLY ACTIVE GLUCOCEREBROSIDASE FROM RECOMBINANT CELLS GENZYME CORPORATION (US) 1992-08-06 WO claimed
EP-0327952-B1 SELF-INDICATING AND IMPROVED RESOLUTION ANALYSES EMPLOYING STOICHIOMETRIC CHEMICAL SUBTRACTION MILES INC. (US) 1992-04-15 EP claimed
EP-0149339-B1 ASSAY FOR NUCLEIC ACIDS MediSense, Inc. (US) 1989-08-23 EP claimed
EP-0327952-A1 Self-indicating and improved resolution analyses employing stoichiometric chemical subtraction MILES INC. (US) 1989-08-16 EP claimed
EP-0308919-A1 Compositions for topical use having melanin synthesis-inhibiting activity Sansho Seiyaku Co., Ltd. (JP) 1989-03-29 EP claimed